Pre- and Postexposure Use of Human Monoclonal Antibody against H5N1 and H1N1 Influenza Virus in Mice: Viable Alternative to Oseltamivir

New strategies to prevent and treat influenza virus infections are urgently needed. A recently discovered class of monoclonal antibodies (mAbs) neutralizing an unprecedented spectrum of influenza virus subtypes may have the potential for future use in humans. Here, we assess the efficacies of CR6261...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Infect Dis
Main Authors: Koudstaal, Wouter, Koldijk, Martin H., Brakenhoff, Just P. J., Cornelissen, Lisette A. H. M., Weverling, Gerrit Jan, Friesen, Robert H. E., Goudsmit, Jaap
Formato: Artigo
Idioma:Inglês
Publicado: The University of Chicago Press 2009
Assuntos:
Major Articles and Brief Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7110231/
https://ncbi.nlm.nih.gov/pubmed/19911992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/648378
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares